Fengju Bai

Fengju (Judy) Bai is a seasoned expert in toxicology with extensive experience in preclinical safety. Significant roles include serving as Director of Development Toxicology at Biogen from June 2019 to December 2021, along with previous positions as Principal Investigator and Principal Scientist in the same field. Prior to Biogen, Fengju held the title of Senior Scientist in NonClinical Development at Merck for a brief period in early 2015, and at Cubist Pharmaceuticals from April 2010 to January 2015. Earlier in the career, Fengju worked as a Research Scientist at Charles River Laboratories from April 2006 to April 2010. Fengju Bai holds a PhD in Toxicology from The University of Texas at Austin and an MD from Tianjin Medical University.